joint pain glp-1 medications may help improve inflammation, but not because they are “anti-inflammatory drugs.” They improve many of the metabolic drivers of chronic inflammation: • Decreasing visceral fat • Improving insulin resistance Dr. Brandy Tafoya | Brandy

Despite these benefits, long-term LC administration has been associated to cardiovascular risks due its conversion to trimethylamine- N -oxide (TMAO) by the gut microbiota

In clinical trials, patients lost an average of about 13.6% of their body weight after one year

Many serums, creams and prescription actives claim to treat the facial changes associated with weight loss including deflation, dehydration, and deep wrinkles

Patients should weigh the convenience of oral medications against the simplicity of weekly injections when deciding which form of semaglutide to use

The wider opportunity lies in understanding how demand for protein, fiber, satiety, and metabolic health is becoming normalized among consumers who have never taken the medications